About Oligodendroglioma
Oligodendroglioma is a type of brain tumor that originates from oligodendrocytes, which are cells that make up the supportive tissue of the brain. These tumors can be classified as either low-grade (grade II) or high-grade (grade III, also known as anaplastic). They are typically found in the cerebral hemisphere of the brain, most often in the frontal and temporal lobes.
Oligodendrogliomas are characterized by their soft, grayish-pink appearance and may contain mineral deposits, areas of hemorrhage, or cysts. Common symptoms include seizures, headaches, and changes in personality.
The exact cause of oligodendrogliomas is unknown, although some cases may involve a chromosome abnormality with loss of chromosomes 1p and 19q.
The exact causes of oligodendroglioma are not fully understood. Oligodendrogliomas are genetic diseases caused by changes in genes (mutations) that control cell function. The gene mutations can increase the growth and spread of cancer cells.
Risk factors include:
- Exposure to radiation
- Family history of brain tumors: Having a family member with a history of brain tumors may increase the risk. It is thought that certain gene changes inherited from family members may lead to a higher risk of developing oligodendrogliomas
- History of epilepsy: People with a history of epilepsy have a slightly higher risk.
- Head trauma: A history of head trauma may also be associated with an increased risk.
It's important to note that these risk factors are not definitive causes, and having one or more does not necessarily mean someone will develop oligodendroglioma. If you have concerns about your individual risk or symptoms, it's best to consult with a healthcare professional for personalized advice.
The most common early symptom of oligodendroglioma is a seizure, which occurs in around 60% of people before diagnosis. Other common symptoms may include:
- Headaches
- Problems with thinking and memory
- Weakness
- Numbness
- Problems with balance and movement
As oligodendroglioma progresses, the symptoms may vary depending on the size and location of the tumor. Some symptoms that may occur at later stages include:
- Paralysis
- Changes to behavior and personality
- Memory loss
- Loss of vision or hearing
- Changes to sense of touch, including difficulty recognizing sensations and inability to recognize objects by touching them
- Difficulty coordinating and balancing
- Difficulty concentrating
- Difficulty reading and writing
- Inability to understand language and music
- Hallucinations,
- Increased seizures
It's important to note that these symptoms can vary from person to person. If you are experiencing any symptoms or have concerns about oligodendroglioma, it's best to consult with a healthcare professional for an accurate diagnosis and appropriate management.
To diagnose oligodendroglioma, doctors commonly perform the following examinations, tests, and procedures:
- Physical exam: The healthcare provider will check for neurological symptoms such as headaches, seizures, vision problems, weakness, or balance issues that could indicate a brain tumor.
- Imaging studies: MRI with contrast is the primary imaging test used to detect and assess brain tumors, including oligodendrogliomas. CT scans may also be used if MRI is not available or to detect calcifications within the tumor.
- Clinical procedures: A neurological exam will be performed to evaluate brain function, including reflexes, coordination, memory, and cognitive abilities.
To determine the stage or severity of oligodendroglioma, doctors may recommend:
- Further imaging studies: Advanced MRI techniques, such as perfusion MRI or magnetic resonance spectroscopy, can help assess tumor growth and metabolism.
- Biopsy: A brain biopsy is performed to obtain a tissue sample from the brain. This sample is tested for genetic markers like 1p/19q codeletion and IDH mutation, which help confirm the diagnosis and guide treatment.
- Lab tests: Blood tests may be ordered to rule out other conditions, but they are not typically used to diagnose oligodendroglioma.
It's important to follow up with your healthcare provider if any symptoms worsen or change after the initial physical exam. They will be able to guide you through the necessary examinations and tests.
The goals of treatment for oligodendroglioma are to:
- Obtain tissue to determine the tumor type
- Remove or reduce as much tumor as possible without causing more symptoms
- Prevent or delay the recurrence of the tumor
The treatments for oligodendroglioma may include:
- Surgery: The first treatment option is surgery to obtain tissue for diagnosis and remove as much tumor as possible.
- Radiation therapy: This treatment uses high-energy beams to destroy cancer cells and shrink tumors. It may be used after surgery to target any remaining tumor cells.
- Chemotherapy: Medications are used to kill cancer cells or stop them from growing. Your healthcare team may recommend a combination of medications based on your individual situation.
- Clinical trials: These studies test new treatments, such as chemotherapy, targeted therapy, or immunotherapy drugs, that may be effective against oligodendroglioma. Participating in a clinical trial can provide access to new treatment options.
- Symptom management: Medications or other treatments may be prescribed to help manage symptoms or complications, such as seizures.
- Health behavior changes: Maintaining a healthy lifestyle, including regular exercise, a balanced diet, and stress management, can support overall well-being during treatment.
It's important to note that the specific treatment plan will depend on factors such as the location of the tumor, overall health, and individual risk factors. Consult with your healthcare professional to determine the most appropriate treatment approach for your situation.
Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.